Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Gemtuzumab Ozogamicin for Pediatric AML

Apr. 24, 2025

Gemtuzumab Ozogamicin for Pediatric AML

AML Awareness Day: New Expert Podcast Series to Understand AML

Apr. 21, 2025

AML Awareness Day: New Expert Podcast Series to Understand AML

Understanding Cancer Cachexia and Its Impact on AML Survival

Apr. 17, 2025

Understanding Cancer Cachexia and Its Impact on AML Survival

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis

Apr. 16, 2025

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis

Targeting ROR1 in Blood Cancers

Apr. 16, 2025

Targeting ROR1 in Blood Cancers

Navigating Financial Uncertainty: Proactive Tips for Blood Cancer Patients and Their Families

Apr. 14, 2025

Navigating Financial Uncertainty: Proactive Tips for Blood Cancer Patients and Their Families

HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah

Apr. 11, 2025

HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs?

Apr. 02, 2025

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs?

Does Fructose Support Cancer Cells?

Apr. 02, 2025

Does Fructose Support Cancer Cells?

New AML Therapy: Pivekimab Sunirine

Mar. 31, 2025

New AML Therapy: Pivekimab Sunirine

How Patients’ Income Impacts Hospital Readmissions in AML

Mar. 27, 2025

How Patients’ Income Impacts Hospital Readmissions in AML

Research Review: Improving Patient Reported Outcome (PRO) Collection and Transparency in Blood Cancer Research

Mar. 27, 2025

Research Review: Improving Patient Reported Outcome (PRO) Collection and Transparency in Blood Cancer Research

Recent Articles

Make an Impact with the HealthTree Challenge: Hike and Wellness Event! image

Make an Impact with the HealthTree Challenge: Hike and Wellness Event!

March 25, 2025

Join us in the Berkshires for a transformative hike & wellness event! Unite with fellow blood cancer fighters from Oct 23-25. Register now!

HealthTree Community Event: Your Treatment Roadmap After AML Diagnosis image

HealthTree Community Event: Your Treatment Roadmap After AML Diagnosis

March 19, 2025

Learn the key steps after an AML diagnosis, treatment options, and how to self-advocate in your journey with insights from Dr. Evan Chen.

Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc. image

Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc.

March 11, 2025

Jenny Ahlstrom, HealthTree's CEO, recognized among Inc.'s top female founders for revolutionizing cancer research through patient-empowering technology.

Treatment Advances

New AML Therapy: Pivekimab Sunirine image

New AML Therapy: Pivekimab Sunirine

Olutasidenib Study Results for Relapsed/Refractory AML image

Olutasidenib Study Results for Relapsed/Refractory AML

FDA Approval of Treosulfan for AML and MDS image

FDA Approval of Treosulfan for AML and MDS

The Latest in Pediatric AML Research and Innovations image

The Latest in Pediatric AML Research and Innovations

Updates in Treatment Options for TP53-Mutant AML and MDS image

Updates in Treatment Options for TP53-Mutant AML and MDS

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib image

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

Load More

Core Education

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML) image

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

What are FLT3 Inhibitors, and How are They Used in AML? image

What are FLT3 Inhibitors, and How are They Used in AML?

What Are The AML Types, and How Are They Classified? image

What Are The AML Types, and How Are They Classified?

Does AML Go to the Brain? image

Does AML Go to the Brain?

What is Relapsed & Refractory AML? image

What is Relapsed & Refractory AML?

What Is The Difference Between Chronic And Acute Leukemia? image

What Is The Difference Between Chronic And Acute Leukemia?

Load More

Trending Articles

AML Awareness Day: New Expert Podcast Series to Understand AML

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs?

Understanding Cancer Cachexia and Its Impact on AML Survival

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

New AML Therapy: Pivekimab Sunirine

Upcoming Events

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Episode 2: Fighting AML in Young Patients: New Research & the Future of CAR-T

Apr 28 / 12:00 EDT

Graft-versus-Host Disease: Understanding It & Navigating Life with It

Graft-versus-Host Disease: Understanding It & Navigating Life with It

Apr 29 / 14:00 EDT

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

Episode 3: Young Adult AML: Understanding the Gaps & Closing Them

May 05 / 12:00 EDT

Patient Stories

articles for Patient Stories

Former NHL Player Kelly Chase Shares an Update on His AML Treatment James' Journey with AML: A Story of Resilience and Acceptance Meet AML Coach, Steve Hodges

HealthTree Research

articles for HealthTree Research

How Blood Cancer Patients Are Finding Purpose, Growth, and Meaning After Diagnosis Share HealthTree Cure Hub to Accelerate AML Research Participate in AML Research: Transportation Survey

Conferences

articles for Conferences

What Works Better for AML: Intensive Chemotherapy or Venetoclax/HMAs? Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients Why Should You Quit Smoking If You Have MDS or AML?

Clinical Trials

articles for Clinical Trials

Gemtuzumab Ozogamicin for Pediatric AML Targeting ROR1 in Blood Cancers Findings from an International Phase 3 Trial: Uproleselan for Relapsed/Refractory AML

HealthTree Press

articles for HealthTree Press

HealthTree Foundation CEO Jenny Ahlstrom Honored as 2025 Remarkable Women Honoree by ABC4 Utah Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc. HealthTree Foundation Launches New Mobile App to Empower Blood Cancer Patients

HealthTree Programs

articles for HealthTree Programs

AML Awareness Day: New Expert Podcast Series to Understand AML Make an Impact with the HealthTree Challenge: Hike and Wellness Event! An Opportunity to Take Action: Regional Cure Teams

Thanks to our sponsors:

All HealthTree resources available anywhere, anytime

Download our App

Download iOS App

Download Android App

iphone app mockup

Download our App

Download iOS App

Download Android App

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811